Journal
Journal for Immunotherapy of Cancer
Publication Date
7-27-2024
Volume
12
Issue
7
First Page
e009074
Document Type
Open Access Publication
DOI
10.1136/jitc-2024-009074
Rights and Permissions
Patel SP, Othus M, Chae YK, Huynh T, Tan B, Kuzel T, McLeod C, Lopez G, Chen HX, Sharon E, Streicher H, Ryan CW, Blanke C, Kurzrock R. Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort. J Immunother Cancer. 2024 Jul 27;12(7):e009074. doi: 10.1136/jitc-2024-009074© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.
Recommended Citation
Patel, Sandip P; Othus, Megan; Chae, Young Kwang; Huynh, Tridu; Tan, Benjamin; Kuzel, Timothy; McLeod, Christine; Lopez, Gabby; Chen, Helen X; Sharon, Elad; Streicher, Howard; Ryan, Christopher W; Blanke, Charles; and Kurzrock, Razelle, "Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: Adrenocortical carcinoma cohort." Journal for Immunotherapy of Cancer. 12, 7. e009074 (2024).
https://digitalcommons.wustl.edu/oa_4/4073
Department
ICTS (Institute of Clinical and Translational Sciences)
